| dc.contributor.author | Bora, Meghali | |
| dc.contributor.author | Hsu, Myat Noe | |
| dc.contributor.author | Khan, Saif A | |
| dc.contributor.author | Doyle, Patrick S | |
| dc.date.accessioned | 2025-02-28T22:00:48Z | |
| dc.date.available | 2025-02-28T22:00:48Z | |
| dc.date.issued | 2022-04 | |
| dc.identifier.uri | https://hdl.handle.net/1721.1/158282 | |
| dc.description.abstract | Conventional formulation strategies for hydrophobic small‐molecule drug products frequently include mechanical milling to decrease active pharmaceutical ingredient (API) crystal size and subsequent granulation processes to produce an easily handled powder. A hydrogel‐templated anti‐solvent crystallization method is presented for the facile fabrication of microparticles containing dispersed nanocrystals of poorly soluble API. Direct crystallization within a porous hydrogel particle template yields core–shell structures in which the hydrogel core containing API nanocrystals is encased by a crystalline API shell. The process of controllable loading (up to 64% w/w) is demonstrated, and tailored dissolution profiles are achieved by simply altering the template particle size. API release is well described by a shrinking core model. Overall, the approach is a simple, scalable and potentially generalizable method that enables novel means of independently controlling both API crystallization and excipient characteristics, offering a “designer” drug particle system. | en_US |
| dc.language.iso | en | |
| dc.publisher | Wiley | en_US |
| dc.relation.isversionof | 10.1002/adhm.202102252 | en_US |
| dc.rights | Creative Commons Attribution-NonCommercial-NoDerivatives | en_US |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | en_US |
| dc.source | Wiley | en_US |
| dc.title | Hydrogel Microparticle‐Templated Anti‐Solvent Crystallization of Small‐Molecule Drugs | en_US |
| dc.type | Article | en_US |
| dc.identifier.citation | Bora, Meghali, Hsu, Myat Noe, Khan, Saif A and Doyle, Patrick S. 2022. "Hydrogel Microparticle‐Templated Anti‐Solvent Crystallization of Small‐Molecule Drugs." Advanced Healthcare Materials, 11 (8). | |
| dc.contributor.department | Massachusetts Institute of Technology. Department of Chemical Engineering | en_US |
| dc.relation.journal | Advanced Healthcare Materials | en_US |
| dc.eprint.version | Final published version | en_US |
| dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
| eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
| dc.date.updated | 2025-02-28T21:46:30Z | |
| dspace.orderedauthors | Bora, M; Hsu, MN; Khan, SA; Doyle, PS | en_US |
| dspace.date.submission | 2025-02-28T21:46:32Z | |
| mit.journal.volume | 11 | en_US |
| mit.journal.issue | 8 | en_US |
| mit.license | PUBLISHER_CC | |
| mit.metadata.status | Authority Work and Publication Information Needed | en_US |